These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9379071)

  • 1. Chronic pain in the setting of Parkinson's disease and depression.
    Stein WM; Read S
    J Pain Symptom Manage; 1997 Oct; 14(4):255-8. PubMed ID: 9379071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain in Parkinson's disease.
    Letro GH; Quagliato EM; Viana MA
    Arq Neuropsiquiatr; 2009 Sep; 67(3A):591-4. PubMed ID: 19722031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.
    Block G; Liss C; Reines S; Irr J; Nibbelink D
    Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa].
    Mizuno J; Kato S; Watada M; Morita S
    Masui; 2009 Oct; 58(10):1286-9. PubMed ID: 19860235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
    Solla P; Fasano A; Cannas A; Mulas CS; Marrosu MG; Lang AE; Marrosu F
    Parkinsonism Relat Disord; 2015 Aug; 21(8):968-71. PubMed ID: 26071817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rhabdomyolysis as a complication of Parkinson's disease].
    Pozzoni P; Tentori F; Corti M; Pozzi C
    G Ital Nefrol; 2002; 19(1):13-7. PubMed ID: 12165940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
    Chang FC; Kwan V; van der Poorten D; Mahant N; Wolfe N; Ha AD; Griffith JM; Tsui D; Kim SD; Fung VS
    J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Catalan MJ; Molina-Arjona JA; Mir P; Cubo E; Arbelo JM; Martinez-Martin P;
    J Neurol; 2018 Jun; 265(6):1279-1287. PubMed ID: 29557989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.
    Pahwa R; Lyons K; McGuire D; Dubinsky R; Hubble JP; Koller WC
    Neurology; 1996 Apr; 46(4):1059-62. PubMed ID: 8780091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
    Băjenaru O; Ene A; Popescu BO; Szász JA; Sabău M; Mureşan DF; Perju-Dumbrava L; Popescu CD; Constantinescu A; Buraga I; Simu M
    J Neural Transm (Vienna); 2016 Apr; 123(4):407-14. PubMed ID: 26699635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain is common in Parkinson's disease.
    Hanagasi HA; Akat S; Gurvit H; Yazici J; Emre M
    Clin Neurol Neurosurg; 2011 Jan; 113(1):11-3. PubMed ID: 20800342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of pain and health-related quality of life in Korean patients with Parkinson's disease.
    Roh JH; Kim BJ; Jang JH; Seo WK; Lee SH; Kim JH; Oh K; Park KW; Lee DH; Koh SB
    Acta Neurol Scand; 2009 Jun; 119(6):397-403. PubMed ID: 18976321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor and non-motor predictors of illness-related distress in Parkinson's disease.
    Sjödahl Hammarlund C; Hagell P; Nilsson MH
    Parkinsonism Relat Disord; 2012 Mar; 18(3):299-302. PubMed ID: 22100143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.
    Fabbri M; Zibetti M; Beccaria L; Merola A; Romagnolo A; Montanaro E; Ferreira JJ; Palermo S; Lopiano L
    Eur J Neurol; 2019 Mar; 26(3):490-496. PubMed ID: 30347489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease.
    Wailke S; Herzog J; Witt K; Deuschl G; Volkmann J
    Eur J Neurol; 2011 Apr; 18(4):590-6. PubMed ID: 20849470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain intensity on and off levodopa in patients with Parkinson's disease.
    Nebe A; Ebersbach G
    Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Painful Parkinson's disease.
    Quinn NP; Koller WC; Lang AE; Marsden CD
    Lancet; 1986 Jun; 1(8494):1366-9. PubMed ID: 2872480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson's disease: a case report.
    Akiyama H; Nukui S; Akamatu M; Hasegawa Y; Nishikido O; Inoue S
    BMC Neurol; 2017 Aug; 17(1):148. PubMed ID: 28774283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.